Biological Characteristics of Mesenchymal Stem Cells during Ex Vivo Expansion

Osipova, E. Y. and Shamanskaya, T. V. and Kurakina, O. A. and Nikitina, V. A. and Purbueva, B. B. and Ustugov, A. Y. and Kachanov, D. Y. and Skorobogatova, E. V. and Dishlevaya, Z. M. and ., S. A. (2011) Biological Characteristics of Mesenchymal Stem Cells during Ex Vivo Expansion. British Journal of Medicine and Medical Research, 1 (3). pp. 85-95. ISSN 22310614

[thumbnail of Rouminetsov_2011BJMMR282.pdf] Text
Rouminetsov_2011BJMMR282.pdf - Published Version

Download (605kB)

Abstract

Mesenchymal stem cells (MSC) have been widely used in different areas of medicine because of their immunosupressive properties and influence on regeneration of the damaged tissues. The objective of this study was to examine the kinetics of growth (MSC from 4-3 passages had significantly higher proliferative activity compared with cultures of 10-12 passages), changes in immunophenotypic characteristics of human MSC in early (3-4) and late (10-12) passages when cultured in vitro as well as study of genetic stability. In the analyzed cultures of MSC was found normal karyotype (46, XY or 46, XX). In most of cultures studied MSC karyotype and the level of aneuploidy remained unchanged even after prolonged culturing.
The author's experience of ex vivo expansion of MSC using both standard medium DMEM with the supplementation of fetal bovine serum (FBS) and serum-free medium MesenCult MSC Basal Medium (Human) (StemCell technologies Inc.) with addition of Mesenchymal Stem Cell Stimulatory Supplements (Human) is presented. The influence of the type of medium on the growth and immunophenotype of MSC is analyzed. The study found that when cultured in serum-free medium proliferative potential of MSCs was lower.

Item Type: Article
Subjects: Research Scholar Guardian > Medical Science
Depositing User: Unnamed user with email support@scholarguardian.com
Date Deposited: 28 Jun 2023 05:29
Last Modified: 16 Jan 2024 04:43
URI: http://science.sdpublishers.org/id/eprint/1246

Actions (login required)

View Item
View Item